Amicus Therapeutics, Inc.
FOLD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $17 | -$24 | -$22 | $15 |
| Dep. & Amort. | $2 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $18 | $25 | $19 |
| Change in WC | -$10 | -$29 | $6 | -$44 |
| Other Non-Cash | $26 | $8 | -$4 | $4 |
| Operating Cash Flow | $36 | -$27 | $8 | -$4 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$18 | -$14 | -$39 | -$36 |
| Inv. Sales/Matur. | $17 | $11 | $6 | $16 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$6 | -$33 | -$20 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$0 | -$0 | -$0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2 | -$0 | -$12 | $1 |
| Financing Cash Flow | -$1 | -$0 | -$12 | $1 |
| Forex Effect | -$1 | $10 | $5 | $3 |
| Net Chg. in Cash | $32 | -$23 | -$32 | -$20 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $159 | $185 | $217 | $237 |
| End Cash | $191 | $162 | $185 | $217 |
| Free Cash Flow | $35 | -$29 | $8 | -$4 |